Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

GH

Guardant Health Inc

Dec 20 • 04:00PM ET

31.67

Dollar change +0.54
Percentage change 1.73	%

Healthcare • Diagnostics & Research • USA • NASD

Peers: ILMN QGEN EXAS FLGT BIO SRPT MYGN NTRA CDNA TXG

| Held by: IWM VTI VB ARKG VXF VBK IWO SCHA VTWO VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-4.24	Insider Own	4.61%	Shs Outstand	123.16M	Perf Week	-8.89%
Market Cap	3.98B	Forward P/E	-	EPS next Y	-2.97	Insider Trans	-0.36%	Shs Float	117.85M	Perf Month	3.23%
Income	-512.41M	PEG	-	EPS next Q	-0.78	Inst Own	103.02%	Short Float	7.78%	Perf Quarter	34.82%
Sales	692.26M	P/S	5.75	EPS this Y	19.46%	Inst Trans	6.22%	Short Ratio	5.14	Perf Half Y	8.87%
Book/sh	-0.49	P/B	-	EPS next Y	13.86%	ROA	-30.72%	Short Interest	9.17M	Perf Year	13.51%
Cash/sh	7.95	P/C	3.98	EPS next 5Y	29.20%	ROE	-609.28%	52W Range	15.81 - 38.53	Perf YTD	17.08%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-8.88%	ROI	-40.93%	52W High	-17.80%	Beta	1.28
Dividend TTM	-	Quick Ratio	5.85	Sales past 5Y	49.27%	Gross Margin	60.24%	52W Low	100.32%	ATR (14)	1.70
Dividend Ex-Date	-	Current Ratio	6.22	EPS Y/Y TTM	-4.21%	Oper. Margin	-74.37%	RSI (14)	45.18	Volatility	6.13% 4.96%
Employees	1779	Debt/Eq	-	Sales Y/Y TTM	29.20%	Profit Margin	-74.02%	Recom	1.42	Target Price	41.80
Option/Short	Yes / Yes	LT Debt/Eq	-	EPS Q/Q	-19.75%	Payout	-	Rel Volume	1.35	Prev Close	31.13
Sales Surprise	12.31%	EPS Surprise	-20.48%	Sales Q/Q	33.87%	Earnings	Nov 06 AMC	Avg Volume	1.78M	Price	31.67
SMA20	-9.44%	SMA50	9.77%	SMA200	22.66%	Trades		Volume	2,414,304	Change	1.73%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-28-24	Upgrade	Guggenheim	Neutral → Buy	$36
Jun-03-24	Resumed	Jefferies	Buy	$32
Apr-24-24	Resumed	Craig Hallum	Buy	$28
Dec-14-23	Initiated	Guggenheim	Neutral
Dec-13-23	Initiated	Wolfe Research	Peer Perform
Nov-13-23	Upgrade	Raymond James	Mkt Perform → Outperform	$27
Sep-28-23	Initiated	Bernstein	Outperform	$34
Sep-27-23	Upgrade	Piper Sandler	Neutral → Overweight	$40
Jul-05-23	Resumed	JP Morgan	Overweight	$65
May-26-23	Upgrade	Citigroup	Neutral → Buy	$28 → $40
May-05-23	Initiated	UBS	Buy	$40
Mar-09-23	Downgrade	Citigroup	Buy → Neutral	$60 → $33
Jan-05-23	Initiated	Scotiabank	Sector Outperform	$36
Nov-01-22	Downgrade	Piper Sandler	Overweight → Neutral	$65 → $50
Oct-19-22	Initiated	Craig Hallum	Buy	$88
Oct-06-22	Initiated	Stephens	Overweight	$99
Aug-25-22	Initiated	Credit Suisse	Outperform	$80
Jun-03-22	Initiated	Piper Sandler	Overweight	$65
Apr-28-22	Resumed	BTIG Research	Buy	$135 → $115
Feb-24-22	Reiterated	Wells Fargo	Overweight	$150 → $115

Show Previous Ratings

Dec-20-24 08:05AM	Meaningful Insights Biotech Analytics (MiBA) and Guardant Health Announce Strategic Partnership to Optimize Use of Biomarker Testing and Data Analytics to Improve Cancer Care (Business Wire)
Dec-19-24 06:00AM	COTA and Guardant Health Partner to Advance Precision Oncology Research and Therapy Development with Real-World Clinicogenomic Data and AI Analytics (Business Wire)
Dec-18-24 08:05AM	Guardant Health Announces Collaboration With Boehringer Ingelheim to Develop Companion Diagnostic for Detection of Specific Mutations in Advanced Lung Cancer (Business Wire) -7.12%
Dec-09-24 08:05AM	Guardant Health to Share New Research Demonstrating Value of Liquid Biopsy Tests, Real-world Data and AI Analytics in Tailoring Treatment Approaches for Breast Cancer at 2024 San Antonio Breast Cancer Symposium (Business Wire)
Dec-02-24 05:00AM	Guardant awarded nearly $293M in false ad trial against Natera (MedTech Dive)
05:09PM	Loading…
Nov-25-24 05:09PM	Federal Court Jury Issues Unanimous Verdict that Natera Engaged in False Advertising and Unfair Competition in Deliberate Attempt to Damage Guardant Health's Colorectal Cancer Test, Guardant Reveal (PR Newswire) +8.42%
Nov-23-24 10:29AM	Guardant Health, Inc. (GH): Among the Most Promising Cancer Stocks According to Hedge Funds (Insider Monkey)
Nov-22-24 02:21PM	Guardant Health (GH) Set To Dominate The Growing Liquid Biopsy Market (Insider Monkey) +5.39%
Nov-20-24 02:44PM	Guardant Health Stock Sees RS Rating Jump To 83 (Investor's Business Daily)
Nov-13-24 05:05PM	Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +6.32%
Nov-12-24 11:55AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
Nov-07-24 05:37PM	Why Guardant Health Stock Blasted 13% Higher on Thursday (Motley Fool) +13.05%
04:05PM	Guardant Health Pops 13% On An 'Impressive' Beat Following Exact Sciences' Flop (Investor's Business Daily)
10:05AM	Guardant Health Rockets 25% On An 'Impressive' Beat Following Exact Sciences' Flop (Investor's Business Daily)
09:37AM	Analyst Report: Guardant Health, Inc. (Morningstar Research)
04:01AM	Loading…
04:01AM	Guardant Health Inc (GH) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... (GuruFocus.com)
Nov-06-24 08:00PM	Guardant Health (GH) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks) +7.53%
06:40PM	Analyst Report: Guardant Health, Inc. (Morningstar Research)
06:15PM	Guardant Health (GH) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
05:13PM	Guardant Health: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Guardant Health Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue Guidance (Business Wire)
Nov-05-24 09:15AM	Unveiling Guardant Health (GH) Q3 Outlook: Wall Street Estimates for Key Metrics (Zacks)
Nov-01-24 07:00AM	Guardant Health to Participate in Upcoming Investor Conferences (Business Wire) +5.12%
Oct-30-24 06:52PM	Why Guardant Health Stock Was the Picture of Health Today (Motley Fool) +5.87% -5.16%
10:01AM	Will Guardant Health (GH) Report Negative Earnings Next Week? What You Should Know (Zacks)
09:30AM	Guardant Health Named to TIME's List of the Best Inventions of 2024 (Business Wire)
Oct-28-24 08:05AM	Guardant Health to Share Data Supporting Critical Role of Blood-Based Testing in Colorectal Cancer Screening at ACG 2024 (Business Wire) +8.24%
Oct-24-24 05:05PM	Roberto A. Mignone Joins Guardant Health Board of Directors (Business Wire)
Oct-15-24 04:05PM	Guardant Health to Report Third Quarter 2024 Financial Results on November 6, 2024 (Business Wire)
Oct-07-24 09:10PM	Deep Track Capital, LP Increases Stake in Guardant Health Inc (GuruFocus.com)
06:42PM	Loading…
Oct-03-24 06:42PM	Analyst Report: Guardant Health, Inc. (Morningstar Research)
Sep-18-24 08:05AM	GOZILA Study Published in Nature Medicine Shows Patients With Advanced Cancer Who Receive Liquid Biopsy-Guided Treatment Using Guardant360 CDx Survive Twice as Long (Business Wire)
Sep-17-24 07:00AM	The Battle Brewing Over Blood Tests for Cancer (The Wall Street Journal)
Sep-13-24 02:00AM	Guardant Health to Share Data at ESMO 2024 Further Demonstrating Strong Performance of Its Precision Oncology Technology in Multiple Advanced Tumor Types (Business Wire)
Sep-10-24 08:00AM	Guardant Health and Policlinico Gemelli Announce Partnership to Establish A Dedicated In-House Liquid Biopsy Testing Service in Italy (Business Wire) +8.58%
Aug-27-24 04:05PM	Guardant Health to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference (Business Wire)
Aug-26-24 12:56PM	Midday movers: PDD Holdings, NVIDIA fall; Xpeng gains (Investing.com) -7.86%
10:40AM	Why Guardant Health Stock Just Crashed 10% (Motley Fool)
Aug-23-24 10:45AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
06:00AM	Sector Spotlight: Top 4 Basket of Diagnostic Stocks (EXAS, GH, ILMN, LUDG) (News Direct)
Aug-22-24 05:00PM	Guardant Health to Ring the Nasdaq Opening Bell on August 28 to Celebrate the Launch of Shield Blood Test for Colorectal Cancer Screening (Business Wire)
Aug-12-24 11:45AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool) +5.07%
Aug-09-24 04:48PM	Analyst Report: Guardant Health, Inc. (Morningstar Research)
Aug-08-24 04:05PM	Guardant Health to Participate in Upcoming Investor Conferences (Business Wire) -10.87%
09:35AM	Guardant Health (GH) Recently Broke Out Above the 20-Day Moving Average (Zacks)
Aug-07-24 07:30PM	Guardant Health (GH) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks) +5.60%
06:50PM	Guardant Health (GH) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
05:49PM	Guardant Health: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Guardant Health Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue Guidance (Business Wire)
08:05AM	Guardant Health COSMOS Study Published in Clinical Cancer Research Validates Utility of Guardant Reveal Liquid Biopsy Test for Predicting Recurrence in Colorectal Cancer (Business Wire)
Aug-06-24 09:15AM	What Analyst Projections for Key Metrics Reveal About Guardant Health (GH) Q2 Earnings (Zacks) +5.27%
Aug-01-24 04:02PM	Why Exact Sciences, Up 27%, Is 'Coiled To Snap Back' After Quarterly Beat (Investor's Business Daily) -5.04%
08:30AM	Guardant Healths FDA-approved Shield Blood Test Now Commercially Available in U.S. as a Primary Screening Option for Colorectal Cancer (Business Wire)
08:00AM	Guardant Health Outcomes Model Confirms the Public Health Importance of Enhanced Colorectal Cancer Screening Outcomes with High Adherence Strategies (Business Wire)
Jul-31-24 09:45AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
Jul-30-24 06:32AM	Guardant Health secures FDA approval for Shield test (Medical Device Network)
05:17AM	Guardant Health (GH) Moves 6.9% Higher: Will This Strength Last? (Zacks)
Jul-29-24 04:06PM	FDA approves Guardant Health's blood test for colon cancer (Yahoo Finance Video) +6.91%
02:16PM	Guardant Health Gets FDA Nod on Colorectal Cancer Blood Test (Investopedia)
07:58AM	Guardant wins FDA approval for colon cancer blood test (MedTech Dive)
06:30AM	Guardant Healths Shield Blood Test Approved by FDA as a Primary Screening Option, Clearing Path for Medicare Reimbursement and a New Era of Colorectal Cancer Screening (Business Wire)
Jul-24-24 04:05PM	Guardant Health to Report Second Quarter 2024 Financial Results on August 7, 2024 (Business Wire)
Jul-23-24 08:05AM	Guardant Health Introduces Major Smart Liquid Biopsy Upgrade to Market-Leading Guardant360 Test, Further Extending Its Best-in-Class Performance (Business Wire)
01:38AM	Guardant settles allegations it violated the False Claims Act (MedTech Dive)
Jul-21-24 06:00AM	3 Precision Medicine Stocks Tailoring Treatments (InvestorPlace)
Jul-18-24 05:00PM	Dr. Manuel Hidalgo Medina Joins Guardant Health Board of Directors (Business Wire)
Jul-05-24 03:01PM	Baillie Gifford Reduces Stake in Guardant Health Inc. (GuruFocus.com)
Jul-03-24 11:11AM	3 Biotech Moonshots With Imminent Catalyst Potential (InvestorPlace)
07:00AM	The 3 Best Personalized Medicine Stocks to Buy in July 2024 (InvestorPlace)
Jul-02-24 06:15AM	From Sell' to Strong Buy': 3 Dramatic Analyst U-Turns to Watch (InvestorPlace)
Jun-27-24 03:28PM	American Cancer Society Projects Over 2 Million New Cases in 2024: Biotech Innovations Respond (PR Newswire)
Jun-26-24 09:35AM	Guardant Health (GH) Just Overtook the 20-Day Moving Average (Zacks)
Jun-25-24 09:55AM	Guardant Health (GH) Now Trades Above Golden Cross: Time to Buy? (Zacks)
Jun-04-24 08:05AM	Guardant Health introduces new Guardant360 TissueNext test with nearly 500 biomarkers to identify more treatment options for patients with advanced cancer (Business Wire)
Jun-03-24 09:18AM	Guardant Health and Washington University to present study at 2024 ASCO meeting highlighting utility of ctDNA to address racial inequities in the use of targeted therapies and enrollment in clinical trials (Business Wire)
May-31-24 08:05AM	Guardant Health Named to TIME100 Most Influential Companies (Business Wire)
May-30-24 08:05AM	Guardant Health to Present Studies at 2024 ASCO Annual Meeting Highlighting Contributions of Its Blood Tests and Real-World Data to Advancing Precision Oncology and Cancer Screening (Business Wire) +5.29%
May-27-24 11:34AM	Bull Market Blastoff: 3 Stocks Targeting 56% to 91% Returns (InvestorPlace)
09:30AM	Guardant Health (GH) Recently Broke Out Above the 200-Day Moving Average (Zacks)
May-24-24 04:06PM	Guardant Health Jumps As Exact Sciences Slumps On A Key FDA Move For Blood Tests (Investor's Business Daily) +13.37%
01:16PM	Guardant Health Stock Jumps 12% (Barrons.com)
01:15PM	Guardant Health Stock Jumps. Blood Test for Cancer Moves Toward FDA Approval. (Barrons.com)
10:28AM	Guardant Stock Climbs As Cancer Test Strides Towards FDA Ok (The Wall Street Journal)
09:03AM	Guardant Health Rockets After FDA Panel Recommends Approval For Blood-Based Colon Cancer Test (Investor's Business Daily)
08:37AM	Guardant wins FDA AdCom backing for colon cancer test (Medical Device Network)
May-23-24 07:03PM	FDA Advisory Committee Panel Strongly Recommends Approval of Shield Blood Test for Colorectal Cancer Screening as a Primary Non-Invasive Screening Option (Business Wire)
10:52AM	Guardant Health's blood test to detect deadly colon cancer is under review by the FDA (Quartz)
07:05AM	Guardant Health Stock Trading Temporarily Halted; FDA Panel to Assess Premarket Approval Application for Shield Blood Test for Colorectal Cancer Screening (Business Wire)
May-22-24 04:05PM	Guardant Health to Participate in Upcoming Investor Conferences (Business Wire) +13.37%
08:15AM	Guardant colon cancer test struggles to detect non-cancerous tumors, FDA says (MedTech Dive)
May-21-24 04:36PM	What's Going On With Colorectal Cancer Diagnostic-Focused Guardant Health Stock On Tuesday? (Benzinga)
09:53AM	Guardant Health Gets EU Certification for Blood-Based Test for Comprehensive Genomic Profiling of Solid Cancers (MT Newswires)
08:05AM	Guardant Health Receives EU IVDR Certification for Guardant360 CDx Liquid Biopsy for Tumor Mutation Profiling Across All Solid Cancers and Companion Diagnostic Indications (Business Wire)
May-17-24 08:05AM	Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
May-16-24 08:05AM	Guardant Health to present real-world data supporting performance of Shield blood test for colorectal cancer screening at 2024 Digestive Disease Week (Business Wire)
May-15-24 06:45PM	Analyst Report: Guardant Health, Inc. (Morningstar Research)
May-13-24 10:03AM	Guardant Health, Inc. (NASDAQ:GH) Q1 2024 Earnings Call Transcript (Insider Monkey) +7.29%
May-10-24 06:16PM	Analyst Report: Guardant Health, Inc. (Morningstar Research) +15.07%
01:58PM	Guardant Health Shares Rise After Q1 Adjusted Loss Shrinks, Revenue Rises; 2024 Revenue Guidance Raised (MT Newswires)
01:09PM	Guardant Health Inc (GH) Reports Strong Q1 2024 Earnings, Surpasses Revenue Estimates (GuruFocus.com)

Guardant Health, Inc. is a precision oncology company engaged in the treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in 2011 and is headquartered in Palo Alto, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Tariq Musa	Director	Dec 18 '24	Sale	34.85	116	4,043	2,810	Dec 19 06:29 PM
Tariq Musa	Director	Dec 18 '24	Proposed Sale	34.85	116	4,043		Dec 18 04:38 PM
Saia John G.	Chief Legal Officer	Dec 15 '24	Option Exercise	0.00	1,020	0	34,095	Dec 16 06:28 PM
POTTER MYRTLE S	Director	Dec 15 '24	Option Exercise	0.00	69	0	13,722	Dec 16 06:26 PM
Kalia Kumud	Chief Information Officer	Dec 15 '24	Option Exercise	0.00	637	0	18,731	Dec 16 06:25 PM
Freeman Chris	Chief Commercial Officer	Dec 15 '24	Option Exercise	0.00	1,402	0	32,854	Dec 16 06:16 PM
EAGLE CRAIG	Chief Medical Officer	Dec 15 '24	Option Exercise	0.00	1,402	0	24,673	Dec 16 06:14 PM
Bell Michael Brian	Chief Financial Officer	Dec 15 '24	Option Exercise	0.00	3,272	0	27,347	Dec 16 06:12 PM
Tariq Musa	Director	Dec 15 '24	Option Exercise	0.00	250	0	2,926	Dec 16 06:11 PM
Tariq Musa	Director	Dec 13 '24	Sale	35.00	2,320	81,200	2,676	Dec 16 06:11 PM
Tariq Musa	Director	Dec 13 '24	Proposed Sale	35.00	2,320	81,200		Dec 13 04:30 PM
Joyce Meghan V.	Director	Dec 04 '24	Option Exercise	0.00	67	0	7,615	Dec 05 06:42 PM
Joyce Meghan V.	Director	Dec 02 '24	Sale	35.90	100	3,590	7,548	Dec 03 07:00 PM
Saia John G.	Chief Legal Officer	Dec 01 '24	Option Exercise	0.00	263	0	33,213	Dec 02 07:27 PM
Kalia Kumud	Chief Information Officer	Dec 01 '24	Option Exercise	0.00	710	0	18,454	Dec 02 07:25 PM
Chudova Darya	Chief Technology Officer	Dec 01 '24	Option Exercise	0.00	316	0	54,941	Dec 02 07:21 PM
Krognes Steve E.	Director	Nov 30 '24	Option Exercise	0.00	154	0	10,065	Dec 02 07:20 PM
Joyce Meghan V.	Director	Dec 02 '24	Proposed Sale	35.90	100	3,590		Dec 02 04:03 PM
Kalia Kumud	Chief Information Officer	Nov 18 '24	Sale	29.25	7,000	204,722	17,744	Nov 19 05:13 PM
Tariq Musa	Director	Nov 15 '24	Option Exercise	0.00	250	0	4,996	Nov 18 07:34 PM
POTTER MYRTLE S	Director	Nov 15 '24	Option Exercise	0.00	68	0	13,653	Nov 18 07:32 PM
Kalia Kumud	Officer	Nov 18 '24	Proposed Sale	29.25	7,000	204,722		Nov 18 04:04 PM
Joyce Meghan V.	Director	Nov 13 '24	Sale	29.90	2,896	86,595	7,648	Nov 14 05:59 PM
CLARK IAN T	Director	Nov 12 '24	Option Exercise	4.18	1,076	4,498	16,753	Nov 14 05:58 PM
CLARK IAN T	Director	Nov 12 '24	Sale	29.45	8,318	244,930	8,435	Nov 14 05:58 PM
Joyce Meghan V.	Director	Nov 13 '24	Proposed Sale	29.90	2,896	86,595		Nov 13 04:27 PM
CLARK IAN T	Director	Nov 12 '24	Proposed Sale	29.45	8,318	244,930		Nov 12 04:24 PM
Joyce Meghan V.	Director	Nov 04 '24	Option Exercise	0.00	66	0	10,544	Nov 05 04:37 PM
Chudova Darya	Chief Technology Officer	Nov 04 '24	Option Exercise	0.00	9,756	0	59,570	Nov 05 04:36 PM
Krognes Steve E.	Director	Oct 31 '24	Option Exercise	0.00	154	0	9,911	Nov 04 05:28 PM
Tariq Musa	Director	Oct 15 '24	Option Exercise	0.00	250	0	4,746	Oct 16 06:33 PM
POTTER MYRTLE S	Director	Oct 15 '24	Option Exercise	0.00	69	0	13,585	Oct 16 06:32 PM
Joyce Meghan V.	Director	Oct 04 '24	Option Exercise	0.00	66	0	10,478	Oct 07 05:22 PM
Saia John G.	Chief Legal Officer	Oct 01 '24	Option Exercise	0.00	7,543	0	36,774	Oct 02 04:56 PM
Kalia Kumud	Chief Information Officer	Oct 01 '24	Option Exercise	0.00	5,877	0	27,724	Oct 02 04:54 PM
Freeman Chris	Chief Commercial Officer	Oct 01 '24	Option Exercise	0.00	8,498	0	35,072	Oct 02 04:53 PM
EAGLE CRAIG	Chief Medical Officer	Oct 01 '24	Option Exercise	0.00	8,284	0	27,471	Oct 02 04:51 PM
Chudova Darya	Chief Technology Officer	Oct 01 '24	Option Exercise	0.00	7,908	0	53,823	Oct 02 04:50 PM
Bell Michael Brian	Chief Financial Officer	Oct 01 '24	Option Exercise	0.00	8,211	0	28,237	Oct 02 04:48 PM
Talasaz AmirAli	Co-Chief Executive Officer	Sep 30 '24	Option Exercise	0.00	11,461	0	2,210,241	Oct 01 05:59 PM
Krognes Steve E.	Director	Sep 30 '24	Option Exercise	0.00	154	0	9,757	Oct 01 05:58 PM
Eltoukhy Helmy	Co-Chief Executive Officer	Sep 30 '24	Option Exercise	0.00	11,461	0	2,310,075	Oct 01 05:51 PM
Tariq Musa	Director	Sep 15 '24	Option Exercise	0.00	249	0	4,496	Sep 16 05:34 PM
Saia John G.	Chief Legal Officer	Sep 15 '24	Option Exercise	0.00	1,019	0	29,748	Sep 16 05:33 PM
POTTER MYRTLE S	Director	Sep 15 '24	Option Exercise	0.00	68	0	13,516	Sep 16 05:32 PM
Kalia Kumud	Chief Information Officer	Sep 15 '24	Option Exercise	0.00	638	0	22,171	Sep 16 05:31 PM
Freeman Chris	Chief Commercial Officer	Sep 15 '24	Option Exercise	0.00	1,402	0	27,171	Sep 16 05:29 PM
EAGLE CRAIG	Chief Medical Officer	Sep 15 '24	Option Exercise	0.00	1,402	0	19,898	Sep 16 05:28 PM
Bell Michael Brian	Chief Financial Officer	Sep 15 '24	Option Exercise	0.00	3,272	0	21,685	Sep 16 05:27 PM
Kalia Kumud	Chief Information Officer	Sep 09 '24	Option Exercise	0.00	6,545	0	24,851	Sep 10 05:00 PM
Chudova Darya	Chief Technology Officer	Sep 09 '24	Option Exercise	0.00	2,909	0	47,175	Sep 10 04:58 PM
Joyce Meghan V.	Director	Sep 04 '24	Option Exercise	0.00	67	0	10,412	Sep 05 04:52 PM
Saia John G.	Chief Legal Officer	Sep 01 '24	Option Exercise	0.00	263	0	29,306	Sep 03 04:47 PM
Kalia Kumud	Chief Information Officer	Sep 01 '24	Option Exercise	0.00	710	0	18,666	Sep 03 04:46 PM
Chudova Darya	Chief Technology Officer	Sep 01 '24	Option Exercise	0.00	316	0	44,379	Sep 03 04:45 PM
Krognes Steve E.	Director	Aug 31 '24	Option Exercise	0.00	155	0	9,603	Sep 03 04:43 PM
Tariq Musa	Director	Aug 15 '24	Option Exercise	0.00	250	0	4,247	Aug 19 05:18 PM
POTTER MYRTLE S	Director	Aug 15 '24	Option Exercise	0.00	68	0	13,448	Aug 19 05:17 PM
Joyce Meghan V.	Director	Aug 04 '24	Option Exercise	0.00	66	0	10,345	Aug 05 06:10 PM
Krognes Steve E.	Director	Jul 31 '24	Option Exercise	0.00	154	0	9,448	Aug 01 06:46 PM
Tariq Musa	Director	Jul 15 '24	Option Exercise	0.00	250	0	3,997	Jul 16 04:35 PM
POTTER MYRTLE S	Director	Jul 15 '24	Option Exercise	0.00	69	0	13,380	Jul 16 04:33 PM
Joyce Meghan V.	Director	Jul 04 '24	Option Exercise	0.00	66	0	10,279	Jul 08 05:29 PM
Saia John G.	Chief Legal Officer	Jul 01 '24	Option Exercise	0.00	974	0	29,391	Jul 02 04:58 PM
Kalia Kumud	Chief Information Officer	Jul 01 '24	Option Exercise	0.00	1,607	0	18,530	Jul 02 04:57 PM
Freeman Chris	Chief Commercial Officer	Jul 01 '24	Option Exercise	0.00	1,928	0	26,527	Jul 02 04:55 PM
EAGLE CRAIG	Chief Medical Officer	Jul 01 '24	Option Exercise	0.00	1,714	0	19,108	Jul 02 04:54 PM
Chudova Darya	Chief Technology Officer	Jul 01 '24	Option Exercise	0.00	1,339	0	44,541	Jul 02 04:53 PM
Talasaz AmirAli	Co-Chief Executive Officer	Jun 30 '24	Option Exercise	0.00	11,462	0	2,204,589	Jul 02 04:51 PM
Krognes Steve E.	Director	Jun 30 '24	Option Exercise	0.00	154	0	9,294	Jul 02 04:49 PM
Eltoukhy Helmy	Co-Chief Executive Officer	Jun 30 '24	Option Exercise	0.00	11,462	0	2,304,423	Jul 02 04:47 PM
Tariq Musa	Director	Jun 15 '24	Option Exercise	0.00	250	0	3,747	Jun 17 06:44 PM
Saia John G.	Chief Legal Officer	Jun 15 '24	Option Exercise	0.00	4,017	0	29,851	Jun 17 06:43 PM
POTTER MYRTLE S	Director	Jun 15 '24	Option Exercise	0.00	68	0	13,311	Jun 17 06:42 PM
Kalia Kumud	Chief Information Officer	Jun 15 '24	Option Exercise	0.00	2,510	0	17,819	Jun 17 06:41 PM
Freeman Chris	Chief Commercial Officer	Jun 15 '24	Option Exercise	0.00	10,402	0	27,469	Jun 17 06:40 PM
EAGLE CRAIG	Chief Medical Officer	Jun 15 '24	Option Exercise	0.00	5,523	0	19,365	Jun 17 06:38 PM
Bell Michael Brian	Chief Financial Officer	Jun 15 '24	Option Exercise	0.00	9,267	0	21,720	Jun 17 06:37 PM
POTTER MYRTLE S	Director	Jun 12 '24	Option Exercise	0.00	5,592	0	13,243	Jun 13 08:58 PM
Krognes Steve E.	Director	Jun 12 '24	Option Exercise	0.00	5,592	0	9,140	Jun 13 08:56 PM
Joyce Meghan V.	Director	Jun 12 '24	Option Exercise	0.00	5,592	0	10,213	Jun 13 08:54 PM
Gadde Vijaya	Director	Jun 12 '24	Option Exercise	0.00	5,592	0	17,640	Jun 13 08:53 PM
CLARK IAN T	Director	Jun 12 '24	Option Exercise	0.00	6,776	0	15,677	Jun 13 08:51 PM
Joyce Meghan V.	Director	Jun 04 '24	Option Exercise	0.00	67	0	4,721	Jun 05 04:56 PM
Joyce Meghan V.	Director	Jun 04 '24	Sale	27.87	100	2,787	4,621	Jun 05 04:56 PM
Saia John G.	Chief Legal Officer	Jun 01 '24	Option Exercise	0.00	263	0	25,928	Jun 03 06:25 PM
Kalia Kumud	Chief Information Officer	Jun 01 '24	Option Exercise	0.00	711	0	15,563	Jun 03 06:23 PM
Chudova Darya	Chief Technology Officer	Jun 01 '24	Option Exercise	0.00	315	0	43,315	Jun 03 06:21 PM
Krognes Steve E.	Director	May 31 '24	Option Exercise	0.00	155	0	3,548	Jun 03 06:20 PM
Tariq Musa	Director	May 15 '24	Option Exercise	0.00	250	0	3,497	May 16 06:17 PM
POTTER MYRTLE S	Director	May 15 '24	Option Exercise	0.00	69	0	7,651	May 16 06:15 PM
EAGLE CRAIG	Chief Medical Officer	May 15 '24	Option Exercise	0.00	3,717	0	15,169	May 16 06:14 PM
Chudova Darya	Chief Technology Officer	May 15 '24	Option Exercise	0.00	8,705	0	46,106	May 16 06:12 PM
Joyce Meghan V.	Director	May 04 '24	Option Exercise	0.00	66	0	4,654	May 06 05:06 PM
Eltoukhy Helmy	Co-Chief Executive Officer	May 03 '24	Option Exercise	4.18	200,000	836,000	2,292,961	May 06 05:05 PM
Talasaz AmirAli	Co-Chief Executive Officer	May 02 '24	Option Exercise	4.18	283,830	1,186,409	2,193,127	May 06 05:03 PM
Krognes Steve E.	Director	Apr 30 '24	Option Exercise	0.00	154	0	3,393	May 02 05:03 PM
Tariq Musa	Director	Apr 15 '24	Option Exercise	0.00	249	0	3,247	Apr 16 06:36 PM
Saia John G.	Chief Legal Officer	Apr 15 '24	Option Exercise	0.00	7,569	0	28,366	Apr 16 06:35 PM
POTTER MYRTLE S	Director	Apr 15 '24	Option Exercise	0.00	68	0	7,582	Apr 16 06:33 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

GH

Guardant Health Inc

Upgrade your FINVIZ experience